Found 4366 articles for: ""
Utility of Pulsed-Dye Laser in the Treatment of Recalcitrant Hailey-Hailey Disease
November 2023 | Volume 22 | Issue 11 | Case Reports | e1 | Copyright © November 2023
Dapsone to Treat Moderate-to-Severe Hidradenitis Suppurativa: A Retrospective Case-Series
November 2023 | Volume 22 | Issue 11 | Features | e12 | Copyright © November 2023
Background: Management of hidradenitis suppurativa (HS) is challenging since no single treatment provides consistently effective results, leaving patients with frequent relapses....
Read MoreINDIVIDUAL ARTICLE: NECOM 3: A Practical Algorithm for the Management of Radiation Therapy-Related Acute Radiation Dermatitis
November 2023 | Volume 22 | Issue 11 | Supplement Individual Articles | SF400354s3 | Copyright © November 2023
Background: In the Nordic European countries in 2020, cancer diagnoses accounted for 175,925 patients. About 50% of cancer patients receive radiation therapy (RT), which may lead...
Read MoreFULL SUPPLEMENT: The Importance of Skincare in Eczema: A Novel Over-the-Counter Routine Improves Signs and Symptoms in Patients with Eczema
October 2023 | Volume 22 | Issue 10 | Department | SF388641s1 | Copyright © October 2023
In the United States, the National Eczema Association estimates that 1 out of every 10 people have some form of eczema over their lifetime. As any dermatologist can attest, managing patients with...
Read MoreFULL SUPPLEMENT: Brodalumab: Five Years of Real-World Safety and Efficiency
October 2023 | Volume 22 | Issue 10 | Department | SF378632s1 | Copyright © October 2023
Psoriasis remains a highly prevalent condition in the United States and worldwide. Preclinical research has been triumphant in elucidating the critical immunological pathways involved in psoriasi...
Read MoreIndividual Article: Evaluation of Efficacy and Tolerability of Two Over-the-Counter Eczema Itch Relief Products
October 2023 | Volume 22 | Issue 10 | Supplement Individual Articles | SF388641s10 | Copyright © October 2023
Background: Study to compare efficacy, tolerability, and patient perception between an over-the-counter itch relief gel (IRG) and itch relief moisturizing cream (IRMC) after a si...
Read MoreIndividual Article: A Novel 3-Step Over-the-Counter Eczema Regimen Improves Eczema Severity, Itch, and Life Quality: Randomized Study
October 2023 | Volume 22 | Issue 10 | Supplement Individual Articles | SF388641s21 | Copyright © October 2023
Background: Eczema, or atopic dermatitis (AD), is a chronic relapsing skin disease associated with unpredictable flares of erythema, rash, and pruritus. AD arises from a combinat...
Read MoreIndividual Article: Over-the-Counter Moisturizers Significantly Improve Skin Hydration in Adults With Eczema/Atopy-Prone Skin
October 2023 | Volume 22 | Issue 10 | Supplement Individual Articles | SF388641s16 | Copyright © October 2023
Background: Many adults suffer from dry, itchy skin, particularly those with eczema-prone skin. This study evaluated the effects of two over-the-counter (OTC) moisturizing produc...
Read MoreIndividual Article: Efficacy of Over-The-Counter Cream in Reducing Eczema Signs
October 2023 | Volume 22 | Issue 10 | Supplement Individual Articles | SF388641s5 | Copyright © October 2023
Background: Eczema (also called atopic dermatitis) is a chronic, relapsing skin disease characterized by erythema, scaling, and pruritus.
Methods: Study 1....
Read MoreThe Association Between Herpes Simplex Virus and Alzheimer's Disease: A Systematic Review
October 2023 | Volume 22 | Issue 10 | Original Article | 1046 | Copyright © October 2023
Alzheimer's disease (AD) is a significant public health concern, affecting more than 6 million Americans; and currently, there are no cure or effective treatment options. The underlying etiology ...
Read MorePost-Hoc Exploratory Pooled Analysis of the Impact of IDP-126 Gel on QoL in Moderate-to-Severe Acne
October 2023 | Volume 22 | Issue 10 | Original Article | 1033 | Copyright © October 2023
Background: Acne has psychosocial effects on patient's quality of life (QoL). This post hoc exploratory analysis of pooled phase 3 data assessed the impact of investigational IDP...
Read MoreA Review of the Current Landscape of Hidradenitis Suppurativa Treatment Development
October 2023 | Volume 22 | Issue 10 | Original Article | 1021 | Copyright © October 2023
Background: Hidradenitis suppurativa (HS) is a chronic inflammatory skin condition characterized by recurrent nodules and abscesses leading to subsequent scarring and tunnel form...
Read MoreSuccessful Treatment of Lichen Planus With Oral Upadacitinib
October 2023 | Volume 22 | Issue 10 | Case Reports | 1058 | Copyright © October 2023
Lichen planus is an auto-inflammatory skin disorder marked by intensely pruritic, violaceous papules that commonly affect the extremities of middle-aged adults.1 There are several trea...
Read MoreCidofovir in the Management of Non-Genital Warts: A Review
October 2023 | Volume 22 | Issue 10 | Original Article | 1009 | Copyright © October 2023
Introduction: Cutaneous warts are one of the most frequent reasons for visits to the dermatologist. While there are many treatment options available and commonly used to treat wa...
Read MoreIndividual Article: Brodalumab Is an Efficacious, Safe, and Cost-Effective IL-17 Receptor Blocker for the Treatment of Moderate-to-Severe Plaque Psoriasis: 2023 Update
October 2023 | Volume 22 | Issue 10 | Supplement Individual Articles | SF378632s5 | Copyright © October 2023
Psoriasis remains a highly prevalent condition in the United States and worldwide. Preclinical research has been triumphant in elucidating the critical immunological pathways involved in psoriasi...
Read MoreSelection of Nemolizumab Clinical Dosage for Atopic Dermatitis
October 2023 | Volume 22 | Issue 10 | Original Article | 1017 | Copyright © October 2023
Nemolizumab is a monoclonal antibody directed against the interleukin-31 receptor A subunit, which is involved in the pathogenesis of pruritus and inflammation in atopic dermatitis (AD). Clinical tria...
Read MoreEnsuring Dermatologists Practice Enhanced Antibiotic Stewardship With Sarecycline Mnemonic
October 2023 | Volume 22 | Issue 10 | Editorials | 1061 | Copyright © October 2023
It must be ensured that dermatologists practice enhanced antibiotic stewardship to combat antimicrobial resistance and negative consequences of microbiome dysbiosis. In order to help achieve this, we ...
Read MoreParticipant Satisfaction of a Community-based Telehealth Clinic for Atopic Dermatitis
October 2023 | Volume 22 | Issue 10 | Editorials | 1066 | Copyright © October 2023
Atopic dermatitis (AD), a chronic, relapsing inflammatory disease that affects more than 30 million children and adults in the US, disproportionally impacts African American (AA) and Hispanic children...
Read MoreOnychomycosis Treatment Prescribed at Only Twenty Percent of Visits: A Cross-Sectional Analysis of the National Ambulatory Medical Care Survey 2007 to 2016
October 2023 | Volume 22 | Issue 10 | Original Article | 1040 | Copyright © October 2023
Background: Onychomycosis represents the highest proportion of nail disorders seen in clinical practice. Onychomycosis management may differ amongst specialties, with impact on patien...
Read MoreKeratosis Pilaris: Treatment Practices of Board-Certified Dermatologists
October 2023 | Volume 22 | Issue 10 | Original Article | 985 | Copyright © October 2023
Keratosis pilaris (KP) is a chronic disorder of follicular hyperkeratinization and perifollicular erythema with lesions affecting the extensor surfaces of arms, upper legs, and buttocks. While there i...
Read MoreMedia and other results for: ""
© 2023 Journal of Drugs in Dermatology. All Rights Reserved. JDD, a peer-reviewed, MEDLINE®/PubMed® indexed journal, offers the dermatology community strong content of utmost quality and relevance on drugs, devices, and methods.
